Back to Search
Start Over
Monte Rosa licenses VAV1 degrader to Novartis
- Source :
- Global Banking News (GBN). October 28, 2024
- Publication Year :
- 2024
-
Abstract
- Global Banking News-October 28, 2024-Monte Rosa licenses VAV1 degrader to Novartis (C)2024 ENPublishing - http://www.enpublishing.co.uk Monte Rosa Therapeutics Inc (Nasdaq:GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Global Banking News (GBN)
- Publication Type :
- Periodical
- Accession number :
- edsgcl.813867849